Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
BBP
67
HOLDINGS
29%
ALSO IN PBE
PBE
28
HOLDINGS
64%
ALSO IN BBP
SECTOR DRIFT (BBP minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
DYNAVAX TECHNOLOGIES CORP | 2.2% | 2.5% | 2.2% |
|
BIOMARIN PHARMACEUTICAL INC | 1.7% | 2.5% | 1.7% |
|
HALOZYME THERAPEUTICS INC | 1.7% | 2.4% | 1.7% |
|
EXELIXIS INC | 1.7% | 2.7% | 1.7% |
|
REGENERON PHARMACEUTICALS | 1.6% | 4.8% | 1.6% |
BBP Overweight Relative to PBE
|
AMICUS THERAPEUTICS INC | 2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | 1.9% |
|
AXSOME THERAPEUTICS, INC. | 1.9% |
|
MIRUM PHARMACEUTICALS, INC. | 1.9% |
|
PHATHOM PHARMACEUTICALS, INC. | 1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 1.7% |
|
TRAVERE THERAPEUTICS, INC. | 1.7% |
|
NUVATION BIO INC CLASS A | 1.7% |
 |
THERAVANCE BIOPHARMA INC | 1.6% |
|
SYNDAX PHARMACEUTICALS INC | 1.6% |
BBP Underweight Relative to PBE
|
ILLUMINA INC | -4.8% |
|
ROYALTY PHARMA PLC CLASS A | -4.7% |
|
BIOGEN IDEC INC | -3.9% |
|
VERTEX PHARMACEUTICALS INC | -3.3% |
|
INCYTE CORP | -3.2% |
|
AMGEN INC | -3.2% |
|
VERACYTE INC | -3.2% |
|
REGENERON PHARMACEUTICALS | -3.2% |
|
EXACT SCIENCES CORP | -3.1% |
|
GILEAD SCIENCES INC | -3.0% |